Home » Phase III Trial of Z-036 Fails to Meet Primary Endpoint
Phase III Trial of Z-036 Fails to Meet Primary Endpoint
AEterna Zentaris Inc. reported Phase 3 results for its European efficacy trial
Z-036 in benign prostatic hyperplasia, with cetrorelix pamoate.
TradingMarkets
TradingMarkets
Upcoming Events
-
23Apr
-
25Apr
-
07May
-
14May
-
30May